The forkhead transcription factors play important roles invascular pathology and immunology

Advances in Experimental Medicine and Biology

Volumn 665, Issue , 2009, Pages 90-105

  Yang, Xiao Feng ^a   Fang, Pu ^b   Meng, Shu ^b   Jan, Michael ^b   Xiong, Xinyu ^b   Yin, Ying ^b   Wang, Hong ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR INFLAMMATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL AGING; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STRESS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INFLAMMATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; THYMOCYTE; VASCULAR SMOOTH MUSCLE; ANIMAL; IMMUNE SYSTEM; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR;

EID: 77952500002     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1599-3_7     Document Type: Article

References (127)

1. Zhou X. Nicoletti A. Elhage Ret al. Transfer of CD4(- ) Tvcells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000; 102:2919-22.
2. Ross R. Atherosclerosis. In: Wyngaarden J Smith LH. Bennett JC. ed, Cecil Textbook of Medicine. Philadelphia. London. Toronto Montreal, Sydney. Tokyo: W.B. Saunders Company. 1992:293-8.
3. Tobias PS. Curtiss LK. Toll-like receptor s in atherosclerosis. Biochem Soc Trans 2007; 35:1453-5.
4. Wang H. Jiang X. Yang F, et al. Hyperhomoc ysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood 2003; 101:3901-3907. (Pubitemid 36857865)
5. Jiang X. Yang F, Tan H, et al. Hyperhomoc ystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler Thromb Vase Bioi 2005; 25:2515-21. (Pubitemid 43732272)
6. Tan H. Jiang X. Yang F, et al. Hyperhomocysteinemia inhibit s post-injur y rcendothelialization in mice. Card iovasc Res 2006; 69:253-62. (Pubitemid 41818973)
7. Xu Q Infections. heat shock proteins and atherosclerosis. Curr Opin Cardiol2003; 18:245-52. (Pubitemid 37041042)
8. Hansson GK. Inflammat ion. Atherosclerosis and coronary artery disease. N Engl J Med 2005; 352:1685-95.
9. YangXF. Factors regulating apoptosis and homeostasis of CD4+CD25highFOXP3 + regulatory 'f-cells are new therapeutic ta rgets. Front Biosci 2008; 13:1472-99.
10. Xiong Z. Song J. YanY, et al. Higher expression of Bax in regulatory Tvcells increases vascular inflammation Front Biosci 2008; 13:7143-55.
11. Xiong Z. YanY. Song J, et al. Expression of TCTP antisense in CD25(high) regulatory T-cells aggravates cuff-injured vascular inflammation. Atherosclerosis 2009; Apr;203(2):401-8.
12. Yan Y. Xiong Z. Zhang S, et al. CD25high T-cells with a prolonged survival inh ibit development of diabetes. Inr J Imrnunopat hol Pharmacol 2008; 21:767-80.
13. Ait-Oufella H, Salomon BL. Potteaux S, et al. Natural regulatory T-cells control the development of atherosclerosis in mice. Nat Med 2006; 12:178-80. (Pubitemid 43214743)
14. Mor A. Planer D. Luboshits G, et al. Role of naturally occurring CD4+ CD25+ regulatory T-cells in experiment al atherosclerosis. Arterioscler Thromb VaseBioi 2007; 27:893-900. (Pubitemid 46606722)
15. Viemann D. Schulze-Osthoff K, RothJ. Potentials and pitfalls of DNA array analysisof the endothelial stress response. Biochim Biophys Acta 2005; 1746:73-84. (Pubitemid 41774282)
16. YangX-F, Ying Yin. Hong Wang. Vascular inflammation and atherosclerosis are activated via receptors for PAMPs and suppressed by regulatory T-cells. Drug Discovery Today Therapeutic Strategies 2009; in press: Doi: L0.1016Ij.ddstr.2008.l1.003.
17. Papanicolaou KN. Izumiya Y. Walsh K. Forkhead transcription factors and cardiovascular biology. Circ Res 2008; 102:16-31.
18. Parmacek MS. Myocardin-related transcription factors: Critical coactivato rs regulating cardiovascular development and adaptation. Circ Res 2007; 100:633-44. (Pubitemid 46594877)
19. Hofmann JJ Iruela-Arispe ML. Notch signaling in blood vessels: Who is talking to whom about what? Circ Res 2007; 100:1556-68. (Pubitemid 46897259)
20. Atkins GB, Jain MK. Role of Kruppel-like transcription factors in endothelial biology. Circ Res 2007; 100:1686-95. (Pubitemid 46987860)
21. Oerrgen P. Regulation of vascular inflammation and remodeling by ETS factors Circ Res 2006 ; 99: 1159-66.
22. Matouk CC. Marsden PA. Epigenetic regulation of vascular endothelial gene expression. Circ Res 2008; 102:873-87. (Pubitemid 351591544)
23. Hannenhalli S. Putt ME. Gilmore JM, et al. Transcriptio nal genomics associates FOX transcription factors with human heart failure. Circulation 2006; 114:1269-76. (Pubitemid 44402052)
24. Weigel D. Jurgens G. Kut tner F, et al. The horneotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo. Cell 1989; 57:645-58.
25. Weigel D. jackle H. The fork head domain: A novel DNA binding motif of eukaryotic transcription factors? Cell 1990; 63:455-6. (Pubitemid 20374090)
26. Maiese K. Chong ZZ. Shang yc. OutFOXOing disease and disability: The therapeutic potential of targeting FoxO proteins. Trends Mol Med 2008; 14:219-27.
27. Burgering BM. A brief introduction to FOXOlogy. Oncogene 2008; 27:2258-62. (Pubitemid 351501787)
28. Kops GJ. de Ruiter ND. De Vries-Smits AM, et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398:630-4. (Pubitemid 29183692)
29. Nemoto S. Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 2002; 295:2450-2. (Pubitemid 34270258)
30. Tran H. Brunet A. Grenier JM, et al. DNA repair pathway stimulated by the forkhead transcrip tion factor FOX03a through the Gadd45 protein Science 2002 ; 296:530-4. (Pubitemid 34408672)
31. Dijkers PF, Medema RH, LammersJW, et al. Expression of the pro -apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr BioI 2000; 10:1201-4.
32. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857-68. (Pubitemid 29165088)
33. Stitt TN, Drujan 0, Clarke BA, et al. The IGF-l/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14:395-403. (Pubitemid 38591410)
34. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin -l and cause skeletal muscle atrophy. Cell 2004; 117:399-412. (Pubitemid 38534545)
35. Skurk C, lzumiya Y, Maatz H, et al. The FOX03a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J BioI Chern 2005; 280:20814-23 (Pubitemid 40776786)
36. Pu igserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXOI-PGC-lalpha interaction. Nature 2003; 423:550-5. (Pubitemid 36648580)
37. Nakae J, BiggsWH 3rd, Kitamura T, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 2002; 32:245-53.
38. Nakae J, Kitamura T, Silver DL, et al. The forkhead transcrip tion factor Foxol (Fkhr) confers insulin sensitivity onto glucose-S-phospharase expression. J Clin Invest 2001; 108:1359-67. (Pubitemid 33107764)
39. Paik JH, Kollipara R, Chu G, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007; 128:309-23. (Pubitemid 46123514)
40. Furuyama T, Kitayama K, Shimoda Y, et al. Abnormal angiogenesis in Foxol (Fkhrj-deficiene mice. J BioI Chern 2004; 279:34741-9. (Pubitemid 39318105)
41. Jacobs FM, van der Heide LP, Wijchers PJ ct al. Fox06, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J BioI Chern 2003; 278:35959-67. (Pubitemid 37139914)
42. Peng SL. Foxo in the immune system. Oncogene 2008; 27:2337-44. (Pubitemid 351501784)
43. Ni YG, Wang N, Cao OJ, et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phospharases, Proc Natl Acad Sci USA 2007; 104:20517-22.
44. Tremblay ML, Giguere V. Phosphatases at the heart of FoxO metabolic control. Cell metabolism 2008; 7:101-3. (Pubitemid 351168562)
45. De Val S, Chi NC, Meadows SM, et al. Combinatorial regulation of endothelial gene expression by ets and forkhead tran scription factors. Cell 2008; 135:1053-64.
46. Abid MR, Shih SC, Otu HH, et al. A novel class of vascular endothelial growth factor-responsive genes that require forkhead activity for expression. J BioI Chern 2006; 281:35544-53. (Pubitemid 46043252)
47. Shaut CA, Keene DR, Sorensen LK, et al. HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification. PLoS Genet 2008: 4:el000073.
48. Chong ZZ, Li F, Maiese K. Oxidative stress in the brain : Novel cellular targets that govern survival during neurodegeneraeive disease. Prog Neurobiol 2005: 75:207-46. (Pubitemid 40693131)
49. Tang ED, Nunez G, Barr FG, et al. Negative regulation of the forkhead transcription factor FKHR by Akt. J BioI Chern 1999; 274:16741-6.
50. Yaffe MB, Rittinger K, Volinia S, et al. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 1997: 91:961-71. (Pubitemid 28027829)
51. Liu P, Kao TP, Huang H. CDKI promotes cell proliferation and survival via phosphorylation and inhibition of FOXOI transcription factor. Oncogene 2008: 27:4733-44.
52. Huang H, Tindall OJ. FOXO factors: A matter of life and death. Future oncology (London, England) 2006; 2:83-9.
53. Miyamoto K, Miyamoto T, Kato Ret al. Fox03a regulates hematopoietic homeostasis through a negative feedback pathway in conditions of stress or aging. Blood 2008; 112:4485-93.
54. Schwarz JB, Langwieser N, Langwieser NN, et al. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury. Involvement of mTORC1. Circ Res 2009: Jan 30;104(2) :189-200, 8p following 200.
55. Dormond O, Madsen JC, BriscoeOM. The effectsof mTOR-Akt interactions on anri-apoptotic signaling in vascular endothelial cells. J BioI Chern 2007; 282:23679-86. (Pubitemid 47311969)
56. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survivalsignals to the cell-intrinsic death machinery. Cell 1997: 91:231-41. (Pubitemid 27456390)
57. Fosbrink M, Niculescu F, Rus V, et al. C5b -9-induced endothelial cell proliferation and migration are dependent on Akt inactivation of forkhead transcription factor FOXO1. J BioI Chern 2006 : 281:19009-18. (Pubitemid 44035404)
58. Skurk C, Maatz H, Kim HS, et al. The Akr-regulated forkhead transcription factor FOX03a controls endothelial cell viability through modulation of the caspase-8 inh ibitor FLIP. J BioI Chern 2004; 279:1513-25. (Pubitemid 38082681)
59. Dernbach E. Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress. Blood 2004 ; 104:3591-7. (Pubitemid 39564432)
60. Rumpold H. Wolf D, Koeck R, et al. Endothelial progenitor cells: A source for therapeutic vasculogenesis? Journal of cellular and molecular medicine 2004; 8:509-18. (Pubitemid 44145483)
61. Dimmeler S. Aicher A. Vasa M, et al. HMG-CoA reductase inhibitors (stanns) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 2001; 108:391-7. (Pubitemid 32730785)
62. Tepper OM, Galiano RD. Capla JM, et al. Human endothelial progen itor cells from type II diabetics exhibit impaired proliferation, adhesion and incorporation into vascular structures Circulation 2002; 106:2781-6. (Pubitemid 35396976)
63. Urbich C, Knau A, Fichtlscherer S, et al. FOXO-dependent expression of the proapoptotic protein Bim: Pivotal role for apoptosis signaling in endothelial progen itor cells. FASEBJ 2005: 19:974-6. (Pubitemid 40827722)
64. Zhu S. Evans S. YanB, et al. Transcriptional regulation ofBim by FOX03a and Akr mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 2008 ; 118:2156-65.
65. Mogi M, Walsh K, Iwai M, et al. Akt-FOX03a signaling affects human endothelial progenitor cell differentiation Hypertens Res 2008: 31:153-9. (Pubitemid 351325627)
66. Potente M, Fisslthaler B, Busse R, et al. 1l,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kipi. J BioI Chern 2003: 278:29619-25 (Pubitemid 36962345)
67. Astorga J, Carlsson P. Hedgehog induction of murine vasculogenesis is mediated by Foxfl and Bmp4. Development 2007: 134:3753-61. (Pubitemid 350104384)
68. Zhao YY, Gao XP. Zhao YO, et al. Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J Clin Invest 2006: 116:2333-43.
69. Zhang HS, Cao EH, Qin JE Homocysteine induces cell cycle Gl arrest in endothelial cells through the P13K/Akt /FOXO signaling pathway. Pharmacology 2005; 74:57-64.
70. Hayashi H. Kume T. Foxc transcription factors directly regulate D1l4and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS ONE 2008: 3:e2401.
71. Zhang Y, Zhang N. Dai B, et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 2008: 68:8733-42.
72. Abid MR, Nadeau RJ, SpokesKC, et al. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells. Arterioscler Thromb Vase BioI 2008: 28:2042-8.
73. Fisslthaler B. Fleming I. Keseru B, et al. Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxOI. Circ Res 2007; 100:el2-21.
74. YuX, Murao K, Imachi H, et al. Regulation of scavengerreceptor class BI gene expression by angiotensin II in vascular endothelial cells. Hypertension 2007: 49:1378-84. (Pubitemid 46809383)
75. Porente M, Urbich C, Sasaki K, et al. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005: 115:2382-92. (Pubitemid 41266200)
76. Heinke J. Wehofsits L, Zhou Q, et al. BMPER is an endothelial cell regulator and controls bone morphogenetic prorein-d-dependenr angiogenesis. Circ Res 2008: 103:804-12.
77. Taddei A, Giampietro C, Conti A, et al. Endothelial adherens junctions control tight junctions by Vli-cadherin-medlated upregulation of claudin-S. Nat Cell Bioi 2008: 10:923-34.
78. Littlewood TD, Bennett MR. Foxing smooth muscle cells: FOX03a-CYR61 connection. Circ Res 2007 ; 100:302-4.
79. Yellaturu CR, Bhanoori M, Neeli I, et al. N-Ethylmaleimide inhibits platelet-derived growth factor Bfl-sdmulared Akr phosphorylation via activation of protein phosphatase 2A. J BioI Chern 2002: 277:40148-55 (Pubitemid 35191007)
80. Suhara T, Kim HS, Kirshenbaum LA, et al. Suppression of Akt signaling induces Fas ligand expression : Involvement of caspase and Jun kinase activation in Akt-mediared Fas ligand regulation Mol Cell Bioi 2002: 22:680-91. (Pubitemid 34027511)
81. Abid MR, Yano K, Guo S, et al. Forkhead transcription factors inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia. J Bioi Chern 2005: 280:29864-73. (Pubitemid 41177064)
82. Sedding DG. Seay U, Fink L, et al. Mechanosensitive p27Kipi regulation and cell cycle entry in vascular smooth muscle cells. Circulation 2003: 108:616-22. (Pubitemid 36961179)
83. Park leW; Kim DH. YouHJ, et al. Activated forkhead transcription factor inhibits neoimimal hyperplasia alter angioplasty through induction of p27. Arterioscler Thromb Vase Bioi 2005: 25:742-7.
84. Lee HY, ChungJW; Youn SW, et al. Forkhead tran scription factor FOX03a is a negative regulato r of angiogenic immediate early gene CYR61, leading to inhibition ofvascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2007; 100:372-80.
85. GrzeszkiewiczTM, Lindner V, Chen N, et al. The angiogenic factor cysteine-rich 61 (CYR61, CCNl) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin alpha(6) betaf l ) and cell surface heparan sulfate proreoglycans. Endocrinology 2002: 143:1441-50. (Pubitemid 34274374)
86. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, et al. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulat ion 2002; 106:254-60. (Pubitemid 34761308)
87. Mo FE, Muntean AG, Chen CC, et al. CYR61 (CCN1) is essential for placental development and vascular integriry. Mol Cell Bioi 2002; 22:8709-20 (Pubitemid 35397184)
88. Shin HS, Lee HJ, Nishida M, et al. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Circ Res 2003; 93:302-10. (Pubitemid 37048242)
89. Liu ZP, Wang Z, Yanagisawa H, et al. Phenotypic modulation ofsmooth muscle cells through interaction of Fox04 and myocardin. Dev Cell 2005; 9:261-70. (Pubitemid 41051744)
90. Luo ZX, Liu EM, Deng Bet al. [Role of Foxp3 expression and CD4+CD25+ regulatory T-cells on the pathogenesis of childhood asthmaJ. Zhonghua Er Ke Za Zhi 2006; 44:267-71.
91. Du KL, Ip HS, Li J, et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol Cell Bioi 2003; 23:2425-37. (Pubitemid 36351024)
92. Chen J, Kitchen CM, StrebJW, et al. Myocardin: A component of a molecular switch for smooth muscle differentiation. Journal of molecular and cellular cardiology 2002; 34:1345-56. (Pubitemid 35244412)
93. Li S, Wang DZ, Wang Z, et al. The serum response factor coactivator myocardin is required for vascular smooth muscle development Proc Natl Acad Sci USA 2003; 100:9366-70. (Pubitemid 37033934)
94. Li M, Chiu JF, Mossman BT, et al. Down-regulation of manganese-superoxide dismutase through phosphorylation of FOX03a by Akt in explanred vascular smooth muscle cells from old rats. J Bioi Chern 2006; 281:40429-39. (Pubitemid 46041846)
95. Li M, Chiu JF, Gagne J, et al. Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOX03a and ERK/Fos pathways in vascular smooth muscle cells. J Cell Physiol 2008; 217:377-87.
96. Allard D, Figg N, Bennett MR, et al. Akt regulates the survival of vascular smooth muscle cells via inhibition of Fox03a and GSK3. J Bioi Chern 2008; 283:19739-47.
97. Kim IM, Ramakrishna S, Gusarova GA, et al. The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Bioi Chern 2005; 280:22278-86. (Pubitemid 40827884)
98. Kalinichenko vv, Gusarova GA, Tan Y, et al. Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Bioi Chern 2003; 278:37888-94. (Pubitemid 37175318)
99. Hansson GK, Libby P. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 2006; 6:508-19. (Pubitemid 43980523)
100. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7:803-15. (Pubitemid 47480307)
101. Jonsson H, Peng SL. Forkhead transcription factors in immunology. Cell Mol Life Sci 2005 ; 62:397-409. (Pubitemid 40379232)
102. Birkenkamp KU, Coffer PJ. FOXO transcription factors as regulators of immune homeostasis: Molecules to die for? J Immunol 2003; 171:1623-9. (Pubitemid 36966442)
103. Kalin TV, Meliton L, Meliron AYet al. Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. Am J Respir Cell Mol Bioi 2008; 39:390-9.
104. BergDT, Myers LJ, Richardson MA, et al. Smad6s regulates plasminogen activator inhibitor-1 through a protein kinase C-beta-dependent up-regulation of transform ing growth factor-beta. J Bioi Chern 2005; 280:14943-7. (Pubitemid 40562845)
105. Ito Y, Daitoku H, Fukamizu A. Foxo1 increases pro-inflammatory gene expression by inducing C/ EBPbeta in TNF-alpha-treated adipocytes. Biochem Biophys Res Commun 2009; 378:290-5.
106. Snoeks L, Weber CR, Turner JR, et al. Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells. Infect Immun 2008; 76:4677-85.
107. Hori S, Sakaguchi S. Foxp3: A critical regulator of the development and function of regulatory T-cells. Microbes Infect 2004; 6:745-51. (Pubitemid 38781186)
108. Maloy KJ, Powrie F. Regulatory Tvcells in the control of immune pathology. Nat Immunol 2001; 2:816-22.
109. Shevach EM. CD4+ CD25+ suppressor T-cells: More questions than answers. Nat Rev Immunol 2002; 2:389-400. (Pubitemid 37328746)
110. Hori S, Nomura T, Sakaguchi S. Control of regulatory T-cell development by the transcription factor Foxp3. Science 2003; 299:1057-61. (Pubitemid 36222930)
111. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function ofCD4+CD25+ regulatory T-cells. Nat Immunol 2003; 4
112. Brunkow ME, Jeffery EW; Hjerrild KA, et al. Disruption ofa new forkhead/winged-helix protein, scurfin, results in the fatallymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27:68-73. (Pubitemid 32044521)
113. Blair PJ, Bultman SJ, Haas JC, et al. CD4+CD8- T-cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse. J Immunol 1994; 153:3764-74. (Pubitemid 24313882)
114. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopachy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27:20-1. (Pubitemid 32044513)
115. Jaeckel E, Mpofu N, Saal N, et al. Role of regulatory T-cells for the treatment of type I diabetes mellitus. Horm Metab Res 2008; 40:126-36. (Pubitemid 351363424)
116. Blackburn CC , Manley NR. Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 2004; 4:278-89. (Pubitemid 38478663)
117. Boehm T, Bleul CC, Schorpp M. Genetic dissection of thymus development in mouse and zebrafish. Immunol Rev 2003; 195:15-27. (Pubitemid 37153450)
118. Nehls M, Pfeifer D, Schorpp M, et al. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 1994; 372:103-7. (Pubitemid 24339492)
119. Bleul CC , Boehm T. Chemokines define distinct microenvironments in the developing thymus. Eur J Immunol 2000; 30:3371-9. (Pubitemid 32005207)
120. Frank J, Pignata C, Panteleyev AA, et al. Exposing the human nude phenotype. Nature 1999; 398:473-4. (Pubitemid 129523577)
121. Fallarino F, Bianchi R, Orabona C, et al. CTLA-4-lg activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 2004; 200:1051-62. (Pubitemid 39431129)
122. Lin L, Hron JD , Peng SL. Regulation ofNF-kappaB, Th activation and auroinflammauon by the forkhead transcription factor Fox03a. Immunity 2004; 21:203-13. (Pubitemid 39094050)
123. Marcinez-Gac L, Marques M, Garcia Z, et al. Control of cyclin G2 mRNA expression by forkhead transcription factors: Novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Bioi 2004; 24:2181-9. (Pubitemid 38248955)
124. So CW; Cleary ML. MLL-AFX requires the transcript ional effector domains of AFX to transform myeloid progenitors and transdominancly interfere with forkhead protein function Mol Cell Bioi 2002; 22:6542-52.
125. Lin L, Spoor MS, Gerth AJ, et al. Modulation of Thl activation and inflammation by the NF-kappaB repressor Foxjl. Science 2004; 303:1017-20. (Pubitemid 38209706)
126. McGarry RC, Walker R, Roder Je. The cooperative effect of the satin and beige mutations in the suppression ofNK and CTL activities in mice. Immunogenetics 1984; 20:527-34. (Pubitemid 15221877)
127. Maiese K, Chong ZZ, Shang YC, et al. FoxO proteins : Cunning concepts and consideration s for the cardiovascular system. Clin Sci (Lond) 2009; 116:191-203.